AAAAI Annual Meeting 2020
Due to the COVID-19 pandemic, The Annual Meeting of the American Academy of Allergy Asthma & Immunology was cancelled for 2020. The theme of this year's meeting was "New Paradigms in the Management of Allergic Disease -- Focus on Biologics."
This resource center will update you on all of the key abstracts from AAAAI 2020 to ensure that you do not miss any of the crucial, practice-changing research that was conducted for presentation at the 2020 Annual Meeting.
Top 5 Abstracts from AAAAI 2020
March 24, 2020Due to COVID-19, the AAAAI Annual Meeting was canceled and the research released to the public. Research highlights included long-term studies from new biologics and important advances in asthma, atopic dermatitis, and immunology care...
Dupilumab Quickly Improves Itching Symptoms in Atopic Dermatitis
March 23, 2020Adolescents and adults with atopic dermatitis (AD) saw improvement in itching symptoms as early as two days after starting on dupilumab...
Mepolizumab Reduces Exacerbations in Patients with Asthma, Comorbid Conditions
March 20, 2020Asthma patients with comorbid conditions such as nasal polyps, sinusitis, or allergic rhinitis had a reduced number of exacerbations and better health-related quality of life after receiving mepolizumab...
FeNO Predicts Exacerbations in Patients with Moderate-to-Severe Asthma
March 19, 2020Fractional exhaled nitric oxide (FeNO) may be a reliable biomarker for predicting exacerbations in patients with moderate-to-severe asthma...
Benralizumab Demonstrates Safety, Efficacy at 3 Years for Moderate-to-Severe Asthma
March 19, 2020At 3 years, benralizumab (Fasenra; AstraZeneca) continues to lower exacerbation rates and improve lung function in adults and adolescents with severe, uncontrolled asthma...